263 related articles for article (PubMed ID: 20162343)
1. Modulation of programmed forms of cell death by intracoronary levosimendan during regional myocardial ischemia in anesthetized pigs.
Grossini E; Caimmi PP; Platini F; Molinari C; Uberti F; Cattaneo M; Valente G; Mary DA; Vacca G; Tessitore L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):5-15. PubMed ID: 20162343
[TBL] [Abstract][Full Text] [Related]
2. Management of acute cardiac failure by intracoronary administration of levosimendan.
Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
Metzsch C; Liao Q; Steen S; Algotsson L
Acta Anaesthesiol Scand; 2007 Jan; 51(1):86-93. PubMed ID: 17073861
[TBL] [Abstract][Full Text] [Related]
4. Milrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism.
Axelsson B; Johansson G; Abrahamsson P; Gupta A; Tydén H; Wouters P; Haney M
Acta Anaesthesiol Scand; 2013 Jul; 57(6):719-28. PubMed ID: 23517167
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of levosimendan in the early stages of endotoxemia.
Cunha-Goncalves D; Perez-de-Sa V; Dahm P; Grins E; Thörne J; Blomquist S
Shock; 2007 Jul; 28(1):71-7. PubMed ID: 17510599
[TBL] [Abstract][Full Text] [Related]
6. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
Sonntag S; Sundberg S; Lehtonen LA; Kleber FX
J Am Coll Cardiol; 2004 Jun; 43(12):2177-82. PubMed ID: 15193677
[TBL] [Abstract][Full Text] [Related]
7. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
[TBL] [Abstract][Full Text] [Related]
9. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Givertz MM; Andreou C; Conrad CH; Colucci WS
Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan in regional myocardial ischemia.
Pieske B
Cardiovasc Drugs Ther; 2002 Sep; 16(5):379-81. PubMed ID: 12656119
[No Abstract] [Full Text] [Related]
11. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig.
Grossini E; Caimmi PP; Molinari C; Teodori G; Vacca G
J Cardiovasc Pharmacol; 2005 Sep; 46(3):333-42. PubMed ID: 16116339
[TBL] [Abstract][Full Text] [Related]
13. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
[TBL] [Abstract][Full Text] [Related]
14. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
[TBL] [Abstract][Full Text] [Related]
15. Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model.
Busk M; Maeng M; Kristensen J; Berg JS; Mortensen UM; Nielsen TT; Nielsen-Kudsk JE
Cardiovasc Drugs Ther; 2006 Oct; 20(5):335-42. PubMed ID: 17122904
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary levosimendan enhances contractile function of stunned myocardium.
Jamali IN; Kersten JR; Pagel PS; Hettrick DA; Warltier DC
Anesth Analg; 1997 Jul; 85(1):23-9. PubMed ID: 9212117
[TBL] [Abstract][Full Text] [Related]
17. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT
Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
[TBL] [Abstract][Full Text] [Related]
18. Effect of the calcium sensitizer levosimendan on the performance of ischaemic myocardium in anaesthetised pigs.
Tassani P; Schad H; Heimisch W; Bernhard-Abt A; Ettner U; Mendler N; Lange R
Cardiovasc Drugs Ther; 2002 Sep; 16(5):435-41. PubMed ID: 12652113
[TBL] [Abstract][Full Text] [Related]
19. Effects of levosimendan in experimental acute coxsackievirus myocarditis.
Latva-Hirvelä J; Kytö V; Saraste A; Vuorinen T; Levijoki J; Saukko P
Eur J Clin Invest; 2009 Oct; 39(10):876-82. PubMed ID: 19772522
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
Biala A; Martonen E; Kaheinen P; Levijoki J; Finckenberg P; Merasto S; Louhelainen M; Muller DN; Luft FC; Mervaala E
Hypertens Res; 2010 Oct; 33(10):1004-11. PubMed ID: 20811386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
